Systemic inflammation induced by NAFLD can not only activate RAAS and SNS by elevated circulating cytokines and complements levels (e.g., IL-6, TNF-α, and CCL2) but also alter adipokine profiles characterized by increased leptin levels and reduced adiponectin concentrations (99). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.